Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Dermatophytosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    33 result(s) found for: Dermatophytosis. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2005-001239-32 Sponsor Protocol Number: EBERTOIII/05ES01 Start Date*: 2005-09-02
    Sponsor Name:Laboratorios SALVAT, S.A.
    Full Title: Ensayo clínico multicéntrico, aleatorizado, paralelo, doble ciego, para evaluar la eficacia y seguridad de eberconazol solución 1% frente a placebo en el tratamiento de las dermatofitosis
    Medical condition: Dermatofitosis
    Disease: Version SOC Term Classification Code Term Level
    10012504
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-002644-23 Sponsor Protocol Number: MB_PDT_1 Start Date*: 2020-07-23
    Sponsor Name:Dept. of Dermatology, Zealand University Hospital, Roskilde
    Full Title: Photodynamic therapy of antifungal resistant dermatophytes
    Medical condition: Competent patients over 18 years old with mycological verified antifungal resistant dermatophytosis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10043870 Tinea infections HLT
    20.0 10021881 - Infections and infestations 10043868 Tinea cruris PT
    20.0 10021881 - Infections and infestations 10060889 Tinea infection PT
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    20.0 10021881 - Infections and infestations 10049591 Tinea imbricata PT
    20.0 10021881 - Infections and infestations 10067197 Tinea manuum PT
    20.0 10021881 - Infections and infestations 10043872 Tinea NOS LLT
    20.1 10021881 - Infections and infestations 10043869 Tinea infection NOS LLT
    20.0 10021881 - Infections and infestations 10043867 Tinea corporis LLT
    20.0 10021881 - Infections and infestations 10043864 Tinea LLT
    20.0 10021881 - Infections and infestations 10053041 Tinea trichophytina cruris LLT
    20.0 10021881 - Infections and infestations 10073383 Tinea of hand LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-000974-54 Sponsor Protocol Number: RD.03.SPR.40026 Start Date*: 2007-02-28
    Sponsor Name:GALDERMA Research & Development
    Full Title: A multi-centre, randomized, parallel groups, vehicle and active controlled study of amorolfine 4% and 10% nail lacquer new formulation in the topical treatment of distal and lateral subungual toena...
    Medical condition: Distal and lateral subungual onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IS (Completed) CZ (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-000561-31 Sponsor Protocol Number: PM1331 Start Date*: 2015-06-15
    Sponsor Name:Polichem S.A.
    Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, VEHICLE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF P-3058 10% NAIL SOLUTION IN THE TREATMENT OF ONYCHOMYCOSIS
    Medical condition: Mild to moderate distal subungual Onychomycosis caused by Dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) LV (Completed) BG (Completed) SE (Completed) DE (Completed) SK (Completed) BE (Completed) PL (Completed) CZ (Completed) LT (Completed) GR (Completed) IS (Completed)
    Trial results: View results
    EudraCT Number: 2008-002418-23 Sponsor Protocol Number: W0027-10 Start Date*: 2008-12-17
    Sponsor Name:Stiefel Laboratories Inc.
    Full Title: A phase 2, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in subjects with distal su...
    Medical condition: Distal subungual onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis PT
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-001028-11 Sponsor Protocol Number: K70-2 Start Date*: 2007-05-24
    Sponsor Name:Moberg Derma AB
    Full Title: A double-blind, placebo-controlled study of efficacy, safety and tolerability of topical Kaprolac® K70 in six months treatment of distal subungual onychomycosis (DSO)
    Medical condition: Distal subungual onychomycosis (DSO)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2006-003508-21 Sponsor Protocol Number: CSFO327N2302 Start Date*: 2006-10-20
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, double-blind, vehicle-controlled, multicenter, parallel group study to assess the efficacy, safety, and tolerability of topical terbinafine hydrogen chloride (HCl) formulation for 24 ...
    Medical condition: Onychomycosis (mild to moderate)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2006-005895-42 Sponsor Protocol Number: TLT-CLI-001 Start Date*: 2009-03-02
    Sponsor Name:TLT Medical Ltd.
    Full Title: A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenails
    Medical condition: Distal/lateral Subungual onychomycosis (DSO) caused by dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022622-32 Sponsor Protocol Number: MOB015-I Start Date*: 2010-11-11
    Sponsor Name:Moberg Derma AB
    Full Title: An open, multi-centre trial comparing the efficacy and safety of two different treatment regimens of topical MOB015 treatment of distal subungual onychomycosis (DSO)
    Medical condition: Distal subungual onychomycosis (DSO)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-002427-90 Sponsor Protocol Number: SD-AMO-00326-08 Start Date*: 2008-10-20
    Sponsor Name:SUBSTIPHARM Développement
    Full Title: Etude en double aveugle de l’équivalence clinique et mycologique du Locéryl® (Amorolfine, solution filmogène à 5%) et de son générique dans le traitement des onychomycoses sans atteinte de la matr...
    Medical condition: Tout patient présentant une onychomycose unguéale sans atteinte matricielle d’un doigt ou d’un orteil n’ayant jamais encore été traité par un antimycosique
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-000544-26 Sponsor Protocol Number: RD.03.SPR.29106 Start Date*: 2013-12-10
    Sponsor Name:Galderma R&D
    Full Title: Determination of antifungal activity of Loceryl® Nail Lacquer 5% when used concomitantly with a cosmetic nail varnish compared to a Loceryl® Nail Lacquer 5% alone in treatment of toenail Distal Sub...
    Medical condition: Mild to moderate toenail Distal Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: View results
    EudraCT Number: 2009-013261-26 Sponsor Protocol Number: K101-I Start Date*: 2009-08-19
    Sponsor Name:Moberg Derma AB
    Full Title: A double-blind, randomized, multi-centre, placebo-controlled study of efficacy and safety of topical K101 in twelve months treatment of distal subungual onychomycosis (DSO)
    Medical condition: Distal subungual onychomycosis (DSO)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-006338-17 Sponsor Protocol Number: CL-067-II-01 Start Date*: 2007-08-22
    Sponsor Name:CPDS BERMUDA, LTD.
    Full Title: OPEN-LABEL STUDY OF EFFICACY AND SAFETY OF 067 (TERBINAFINE IN TRANSFERSOME®) FOR THE TREATMENT OF ONYCHOMYCOSIS
    Medical condition: Bilateral onychomycosis of the hallux nail (great toe) with positive mycosis culture and KOH microscopy as per central laboratory, otherwise healthy according to physical examination
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003506-25 Sponsor Protocol Number: CSFO327N2301 Start Date*: 2007-03-01
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, double-blind, vehicle-controlled, multicenter, parallel group study to assess the efficacy, safety, and tolerability of topical terbinafine hydrogen chloride (HCl) formulation for 24 ...
    Medical condition: Onychomycosis (mild to moderate)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: View results
    EudraCT Number: 2009-011125-14 Sponsor Protocol Number: RV4104A-2008-548 Start Date*: 2009-07-06
    Sponsor Name:Pierre Fabre Dermatologie
    Full Title: A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solutio...
    Medical condition: Patients suffering from distal-lateral or lateral subungual onychomycosis of one great toenail (the target nail) without matrix involvement
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-004331-27 Sponsor Protocol Number: P05205 Start Date*: 2008-12-23
    Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation
    Full Title: A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of SCH 900340 5% Solution Compared with Vehicle Administered Topically in the Treatment of Dist...
    Medical condition: Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) IS (Prematurely Ended) BE (Completed) SE (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-005595-17 Sponsor Protocol Number: PMPed-004 Start Date*: 2014-02-11
    Sponsor Name:Polichem S.A.
    Full Title: Multicentre, open label study to assess the tolerability of P-3058 nail solution in paediatric patients affected by mild-to-moderate onychomycosis
    Medical condition: Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    16.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed) DE (Completed) BE (Completed) LV (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-002399-92 Sponsor Protocol Number: MP/clin/001-Ter Start Date*: 2008-10-08
    Sponsor Name:MedPharm Ltd.
    Full Title: A phase IIa randomised, observer-blind, comparative study of the efficacy, tolerability and consumer acceptability of topical MedSpray™ TP 1 % versus Lamisil® Once 1 % in the treatment of tinea pedis
    Medical condition: tinea pedis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10043873 Tinea pedis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-002707-10 Sponsor Protocol Number: PM0731 Start Date*: 2009-03-04
    Sponsor Name:Polichem SA
    Full Title: MULTICENTRE, RANDOMIZED, DOUBLE BLIND WITHIN FREQUENCY OF ADMINISTRATION, PLACEBO CONTROLLED, DOSE-FINDING, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF 3 DOSES OF P-3058 NAIL LACQUER (5% o.d., 10%...
    Medical condition: Mild to moderate distal subungual Onychomycosis due to Dermatophytes.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) LV (Completed) IT (Completed) FR (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2006-003570-10 Sponsor Protocol Number: CSFO327N2303 Start Date*: 2007-03-02
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, open-label, active-controlled, multicenter, parallel group study to assess the efficacy, safety and tolerability of topical 10% terbinafine hydrogen chloride (HCl) formulation versus ...
    Medical condition: mild to moderate toenail onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed) FI (Completed) HU (Completed) ES (Completed) FR (Completed) DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 04 07:40:32 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA